Author:
Alhossein Abdulkarim,Abaoud Abdulrahman Abdullah,Becker David,Aldabas Rashed,Bakhiet Salaheldin Farah,Al Jaffal Mohammed,Alsufyani Manar,Abdu Elrahim Nagda Mohamed,Alzrayer Nouf
Abstract
The ADHD Rating Scale—5 for Children and Adolescents, School Version, has been adopted and validated to be used in assessing ADHD among school children within Western contexts. However, there are few assessment tools in use for identifying ADHD characteristics in children in Sudan. Therefore, this study aimed to investigate the psychometric properties of this rating scale in the context of Sudan. To accomplish this, data were collected on a sample of 3,742 school-aged children and adolescents as reported by their teachers. Psychometric properties can be classified as very good, with very high reliability (>0.90), and high construct validity tested by exploratory and confirmatory factor analysis. Thus, the ADHD Rating Scale—5 for Children and Adolescents, School Version, is valid, reliable, and suitable to use for assessing ADHD symptoms among children and adolescents in the Sudanese context.
Reference70 articles.
1. Diagnosing ADHD in children and adults;Adler,2015
2. The effectiveness of a treatment program in improving attention-deficit/hyperactivity disorder among students with learning disabilities in the basic stage in Khartoum locality;Ahmed;Int. J. Educ. Psychol. Sci.,2018
3. Spectrum of attention deficit hyperactivity disorders (ADHD) among Sudanese children with epilepsy;Ahmed;Sudan. J. Pediatr.,2015
4. Conceptual and linguistic equivalence of the revised Connors estimation scales when applied to a Sudanese sample;Al-Awad;J. Educ. Psychol. Res.,2019
5. The application of the Conners' rating scales to a Sudanese sample: an analysis of parents' and teachers' ratings of childhood behaviour problems;Al-Awad;Psychol. Psychother.,2002
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comorbid Diagnosis of ASD and ADHD: Assessment and Treatment Considerations;Clinical Handbook of ADHD Assessment and Treatment Across the Lifespan;2023